26,136 Shares in LENSAR, Inc. $LNSR Acquired by Cubist Systematic Strategies LLC

Key Points

• Cubist Systematic Strategies LLC has invested approximately $369,000 in LENSAR, Inc., acquiring 26,136 shares, representing about 0.22% of the company.
• Several other institutional investors have also purchased shares of LENSAR in the first quarter, leading to 40.15% of the stock being owned by them collectively.
• LENSAR reported a loss of ($0.15) earnings per share in its recent quarterly earnings, missing analysts' estimates, while its revenue for the quarter was $11.36 million, below the expected $16.55 million.

Cubist Systematic Strategies LLC bought a new position in LENSAR, Inc. (NASDAQ:LNSR - Free Report) during the first quarter, according to its most recent disclosure with the SEC. The institutional investor bought 26,136 shares of the company's stock, valued at approximately $369,000. Cubist Systematic Strategies LLC owned 0.22% of LENSAR at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of LNSR. Groupe la Francaise purchased a new stake in shares of LENSAR in the 1st quarter worth about $1,779,000. OMERS ADMINISTRATION Corp bought a new position in LENSAR in the 1st quarter worth about $1,680,000. Huntleigh Advisors Inc. bought a new position in LENSAR in the 1st quarter worth about $1,069,000. Draper Asset Management LLC bought a new position in LENSAR in the 1st quarter worth about $565,000. Finally, Tabor Asset Management LP bought a new position in LENSAR in the 1st quarter worth about $452,000. 40.15% of the stock is owned by hedge funds and other institutional investors.

LENSAR Price Performance

LENSAR stock traded up $0.34 during mid-day trading on Friday, reaching $12.47. The stock had a trading volume of 58,511 shares, compared to its average volume of 65,129. The company has a market capitalization of $148.83 million, a price-to-earnings ratio of -2.96 and a beta of 0.49. The company has a 50-day moving average price of $12.74 and a two-hundred day moving average price of $13.36. LENSAR, Inc. has a one year low of $3.80 and a one year high of $17.31.

LENSAR (NASDAQ:LNSR - Get Free Report) last announced its quarterly earnings results on Thursday, August 7th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.08) by ($0.07). The firm had revenue of $11.36 million during the quarter, compared to the consensus estimate of $16.55 million. LENSAR had a negative return on equity of 737.30% and a negative net margin of 84.49%.

About LENSAR

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.